Versant Capital Management’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,449
| Closed | -$37.7K | – | 2804 |
|
|
2025
Q4 | $37.7K | Buy |
2,449
+1,194
| +95% | +$13.2K | ﹤0.01% | 1238 |
|
|
2025
Q3 | $12.5K | Sell |
1,255
-1,589
| -56% | -$16.5K | ﹤0.01% | 1841 |
|
|
2025
Q2 | $28.2K | Buy |
2,844
+2,497
| +720% | +$26.3K | ﹤0.01% | 1322 |
|
|
2025
Q1 | $4.5K | Sell |
347
-413
| -54% | -$5.46K | ﹤0.01% | 2062 |
|
|
2024
Q4 | $9.71K | Buy |
760
+710
| +1,420% | +$8.59K | ﹤0.01% | 1414 |
|
|
2024
Q3 | $557 | Hold |
50
| – | – | ﹤0.01% | 1850 |
|
|
2024
Q2 | $562 | Hold |
50
| – | – | ﹤0.01% | 1779 |
|
|
2024
Q1 | $621 | Hold |
50
| – | – | ﹤0.01% | 1647 |
|
|
2023
Q4 | $699 | Hold |
50
| – | – | ﹤0.01% | 1601 |
|
|
2023
Q3 | $739 | Hold |
50
| – | – | ﹤0.01% | 1612 |
|
|
2023
Q2 | $646 | Buy |
+50
| New | +$570 | ﹤0.01% | 1750 |
|
|
2016
Q4 | – | Sell |
-50
| Closed | – | – | 1417 |
|
|
2016
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 1399 |
|
|
2016
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 1360 |
|
|
2016
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 1359 |
|
|
2015
Q4 | $1K | Buy |
+50
| New | +$1.25K | ﹤0.01% | 1219 |
|
Other funds holding DVAX
Versant Capital Management's DVAX Position: Q1 2026 in Review
Versant Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 2,449 shares — an estimated $37.7K sold.
Versant Capital Management first reported a position in DVAX in Q4 2015 and held it in 15 quarters. The position peaked at $37.7K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Versant Capital Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Versant Capital Management sold 2,449 Dynavax Technologies shares in Q1 2026, an estimated $37.7K.
- Versant Capital Management first reported a position in Dynavax Technologies in Q4 2015 and held it in 15 quarters.
- Versant Capital Management's Dynavax Technologies position peaked at $37.7K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.